COPD Exacerbation
Pneumonia in Older Adult
Bronchiectasis
COPD with Heart Failure and Anxiety
Cystic Fibrosis (Teen)
Acute Asthma
COVID-19 Recovery
Pulmonary Fibrosis
Mr. Thompson is a 74-year-old retired builder with GOLD stage III COPD (FEV₁ = 36% predicted). He presents with increased shortness of breath, purulent sputum, and fatigue. He lives alone in a ground-floor flat and smokes 10 cigarettes daily. Regular meds include tiotropium, salbutamol, and prednisolone. On arrival to hospital, his RR is 26, HR 98, SpO₂ 86% on room air, and he is now on 2L/min O₂ via nasal cannula.
Arterial Blood Gas: pH 7.31, PaCO₂ 7.0 kPa, PaO₂ 7.8 kPa, HCO₃⁻ 29, Base Excess +4
1. What does this ABG result indicate?
2. Which clinical sign suggests an infective exacerbation?
3. What is the target SpO₂ range in COPD patients on oxygen?
4. What airway clearance technique is most appropriate here?
5. What is the main role of physiotherapy in the acute phase?
6. Which exercise assessment is most appropriate at discharge planning?
7. Which medication is NOT typically used in COPD exacerbation management?
8. What lifestyle factor most contributes to COPD progression?
9. What is the best discharge referral for ongoing rehab?
10. What social factor should be addressed prior to discharge?
Mrs. Patel presents with a 5-day history of fever, productive cough with yellow sputum, pleuritic chest pain, and general malaise. She's recently returned from a coach holiday and lives with her husband. She is normally independent, but has a history of Type 2 diabetes and hypertension. On examination: RR 28, HR 106, Temp 38.3°C, SpO₂ 90% on room air. Auscultation reveals bronchial breath sounds and coarse crackles at the right lower lobe. She is on IV co-amoxiclav and has been commenced on 2L O₂ via nasal cannula.
1. Which clinical sign is most consistent with lobar pneumonia?
2. What CURB-65 score component does SpO₂ fall under?
3. What is the purpose of early physiotherapy input?
4. What breathing strategy should be encouraged?
5. Which of the following is a red flag requiring medical escalation?
6. What is the most appropriate outcome measure on day 1?
7. Which drug is most appropriate based on her presentation?
8. What strategy is key for preventing deconditioning?
9. What is an appropriate physiotherapy goal for day 3?
10. What discharge advice is most appropriate?
Ms. Lawson has a 10-year history of bronchiectasis, secondary to recurrent childhood pneumonia. She presents with increased cough, purulent sputum, and reduced exercise tolerance. She lives with her teenage daughter and uses a flutter device daily. Her medications include salbutamol inhaler, carbocisteine, and azithromycin (3x/week). On assessment: RR 22, SpO₂ 94% on room air, audible coarse crackles. Chest X-ray shows chronic changes. She reports using 3 pillows to sleep due to postural drainage needs.
1. What is the hallmark feature of bronchiectasis on imaging?
2. What sputum characteristic is common in exacerbations?
3. Which airway clearance technique is she already using?
4. Which of the following is a typical complication of untreated bronchiectasis?
5. What is the purpose of carbocisteine in this patient?
6. What position may assist her postural drainage overnight?
7. What is a physiotherapy indicator of treatment success?
8. What role does azithromycin play in her care?
9. What should be assessed before recommending airway clearance techniques?
10. What long-term outcome measure can track function?
Mr. Lewis underwent elective abdominal surgery (colectomy) 3 days ago. He is experiencing reduced oxygen saturation (SpO₂ 91% on air), mild confusion, and a productive cough. Auscultation reveals decreased air entry in the left lower zone. CXR confirms basal atelectasis. Past history includes hypertension and mild COPD. He is bed-bound and reluctant to mobilise due to pain (rated 6/10 on movement). He has an indwelling catheter and is on morphine PCA.
1. What is the likely cause of his respiratory complication?
2. What physiotherapy priority should be addressed first?
3. What breathing technique is most suitable initially?
4. What impact does the morphine PCA have on respiratory function?
5. What is a functional early goal?
6. What role does positioning play?
7. What is a contraindication to vigorous airway clearance in this patient?
8. What outcome measure could track progress over next few days?
9. What role does early mobilisation play?
10. What MDT referral might support recovery?
Jamie is a 15-year-old student with a known diagnosis of cystic fibrosis. He presents for his annual inpatient tune-up with increased cough and thick sputum. He’s underweight (BMI 16.8), reports fatigue, and struggles to keep up with school sports. He uses a PEP mask daily and receives nebulised hypertonic saline. Medications include Creon, azithromycin, dornase alfa, and salbutamol. SpO₂ is 93% on air; RR 22; auscultation reveals coarse crackles bilaterally. Sputum cultures show Pseudomonas aeruginosa colonisation.
1. What is the primary pathophysiology of CF affecting the lungs?
2. What is the purpose of dornase alfa in CF care?
3. What technique is Jamie using for secretion clearance?
4. What is the significance of Pseudomonas colonisation in CF?
5. What nutritional issue is most common in CF?
6. What outcome measure might be appropriate in adolescent CF physiotherapy?
7. What is a physiotherapy focus during inpatient care?
8. What is the role of nebulised hypertonic saline?
9. What is an important psychosocial factor in adolescent CF care?
10. What is a realistic discharge goal for Jamie?
Sarah, a 29-year-old teacher with a known history of asthma since childhood, presents to A&E with severe shortness of breath, tight chest, and audible wheeze after exposure to cat hair. She is tachypnoeic (RR 32), tachycardic (HR 118), and has SpO₂ 91% on air. She’s using accessory muscles and can only speak in short phrases. ABG shows: pH 7.36, PaCO₂ 5.9, PaO₂ 8.6. Her usual meds are salbutamol (as needed) and budesonide/formoterol (daily). She’s had two similar episodes this year.
1. What is the most concerning feature in this presentation?
2. Which treatment should be administered immediately?
3. What does a normal PaCO₂ indicate during an asthma attack?
4. What physiotherapy approach is appropriate in the acute phase?
5. What is a known trigger in this case?
6. What longer-term adjustment should be made?
7. Which position optimises breathing in asthma?
8. What outcome measure tracks functional impact of asthma?
9. What role can a physiotherapist play post-attack?
10. What is a red flag requiring immediate escalation?
Mr. Ahmed was admitted 3 weeks ago with severe COVID-19 pneumonia. He required 5 days in ICU with high-flow oxygen and dexamethasone. Now transferred to the ward, he is on 2L O₂ via nasal cannula (SpO₂ 93%), with persistent exertional breathlessness, fatigue, and reduced mobility. Pre-morbidly he was a taxi driver, independent in ADLs, and lived with his wife. He currently mobilises 10m with a rollator and experiences a Borg breathlessness score of 5.
1. What respiratory pattern is common in post-COVID patients?
2. Which breathing strategy is appropriate?
3. What long-term complication is common post-COVID?
4. What outcome measure is ideal for tracking his fatigue?
5. What key MDT referral may support this patient?
6. What is a safe discharge goal?
7. What should be avoided during early mobilisation?
8. What exercise tool might support home rehab?
9. What cognitive effect is common post-COVID?
10. What breathing technique helps calm anxiety during breathlessness?
Mr. Hughes has idiopathic pulmonary fibrosis (IPF) diagnosed 2 years ago. He presents to outpatient respiratory physio with worsening exertional dyspnoea and a chronic dry cough. He uses 1L/min home oxygen via nasal cannula. He lives with his wife, is retired, and struggles with housework due to breathlessness. On examination: RR 24, SpO₂ 88% on walking, bibasal fine crackles. Medications include pirfenidone, omeprazole, and salbutamol PRN. He rates his MRC Dyspnoea Score as Grade 3.
1. What type of lung disease is IPF?
2. What is a classic auscultation finding in IPF?
3. What does the MRC Dyspnoea Scale assess?
4. What exercise strategy is recommended?
5. What is the role of pirfenidone?
6. What functional test is commonly used in IPF rehab?
7. What strategy can reduce desaturation during exercise?
8. What is a red flag in IPF requiring escalation?
9. What role can physiotherapy play long-term?
10. What psychological aspect must be considered?
Mr. Grant is in ICU following emergency bowel surgery. He has been intubated for 6 days and has now developed ventilator-associated pneumonia (VAP). He is ventilated on pressure support mode, FiO₂ 0.4, PEEP 5. Sputum is purulent; CXR shows consolidation. His RR is 28, HR 95, Temp 38.2°C, SpO₂ 92%. Sedation has been reduced and he intermittently opens eyes. Noradrenaline has been weaned off. He is receiving enteral nutrition via NG tube.
1. What defines ventilator-associated pneumonia?
2. What physiotherapy intervention is a priority?
3. What is the role of PEEP in mechanical ventilation?
4. When should passive movements begin in ICU?
5. What risk does long-term ventilation pose?
6. What outcome measure tracks sedation levels?
7. What is a barrier to early mobilisation in ICU?
8. What does the SOFA score assess?
9. Which MDT role is crucial at this stage?
10. What is an appropriate initial mobility goal?
Mrs. Donovan has motor neurone disease (MND) and is now experiencing increased breathlessness and weak, ineffective cough. Her peak cough flow is 170 L/min. SpO₂ on air is 95%, but she experiences nocturnal desaturations. She uses NIV (BiPAP) overnight. She has difficulty managing secretions and mild bulbar symptoms. She lives with her partner and receives daily carer visits. Current medications include riluzole and mucolytics.
1. What respiratory pattern is common in MND?
2. What device supports overnight ventilation in neuromuscular disease?
3. What is the significance of a cough peak flow < 270 L/min?
4. What physiotherapy equipment may support cough in MND?
5. What is a common outcome of bulbar dysfunction?
6. What MDT referral is essential in managing bulbar issues?
7. What positioning may support secretion drainage?
8. What is the goal of physio in progressive neuromuscular disease?
9. What education should be provided to carers?
10. What is a realistic outcome goal for Mrs. Donovan?
Mr. Richards is referred for respiratory physiotherapy with worsening breathlessness, daytime somnolence, and morning headaches. BMI is 43 kg/m². He uses CPAP for comorbid OSA. ABG shows PaCO₂ 7.0, PaO₂ 7.5, and HCO₃⁻ 30. He is desaturating to 89% on minimal exertion. Chest wall movement is restricted. Lives with partner and has limited mobility indoors. He has a history of hypertension and type 2 diabetes.
1. What feature defines OHS?
2. What daytime symptom is typical of OHS?
3. What effect does raised bicarbonate suggest?
4. What physical barrier contributes to hypoventilation?
5. What is the role of CPAP in OHS?
6. What additional ventilation may be required?
7. What physio goal is most appropriate short-term?
8. Which education topic is critical?
9. What long-term team should be involved?
10. What is a safe and measurable discharge goal?